• Cost-Effectiveness of Inflectra® Vs. Remicade® for Ankylosing Spondylitis in Germany

    Oct 1, 2017, 00:00

  • Enhancement Program For Couples Adjustment To Failed Assisted Reproductive Technology

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life of Patients with Osteoporosis Treated with Teriparatide

    Oct 1, 2017, 00:00

  • The Epidemiology Of Adult Immune (Idiopathic) Thrombocytopenic Purpura (ITP) In Finland- Resource Utilisation, Related Costs And Hospital Medication Associated With The Treatment Of Non-Splenectomised Adult Itp Based On Real World Data From ...

    Oct 1, 2017, 00:00

  • Listening to the “Patient Voice” to Improve Design and Interpretation of Secondary Analyses- An Example in Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients- A Real-World Study In Sweden

    Oct 1, 2017, 00:00

  • Are Pharmaceutical Companies Prioritizing Multi-Indication Drugs?

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Economic Assessment of NT-PROBNP Test for Acute Heart Failure at Brazilian Private Payer Perspective

    Oct 1, 2017, 00:00

  • What Do The Single Technology Appraisals of The Past Tell US About Fast-Tracking The Most Cost-Effective New Technologies In The Future?

    Oct 1, 2017, 00:00

  • A Real World Evidence Model To Compare Direct Oral Anticoagulants Safety Outcomes For Atrial Fibrillation Patients In Spain

    Oct 1, 2017, 00:00

  • Work Productivity in Brazilian Patients with Moderate-to-Severe Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness and Budget Impact of New Therapies for Metastatic Melanoma in Italy

    Oct 1, 2017, 00:00

  • Second-Line Treatments For Advanced Gastric Cancer- A Network Meta-Analysis Of Overall Survival Using Parametric Modelling Methods

    Oct 1, 2017, 00:00

  • Assessment of Medicines For Very Rare Conditions- Review of A New Approach within The Scottish Medicines Consortium

    Oct 1, 2017, 00:00

  • Cost-Savings In Process Innovations; A Case Example In Myocardial Infarction Patients

    Oct 1, 2017, 00:00

  • Impact of Different Baseline Definitions on The Incidence of Relevant Outcomes Associated with Cancer Following An Advanced Non-Small Cell Lung Cancer (NSCLC) Diagnosis

    Oct 1, 2017, 00:00

  • Identification of Assessment and Funding Models Applicable to Companion Diagnostics in UK, France And Germany

    Oct 1, 2017, 00:00

  • ALK Immunohistochemical Test In The Detection Of Patients Affected By ALK+ Non-Small Cell Lung Cancer- Clinical And Budget Impact

    Oct 1, 2017, 00:00

  • Variation Trend of Annual Medical Cost Forseveralkinds of Malignant Tumors in China- Analysis Based on A Regional Public Health Insurance Claim Database (2011-2015)

    Oct 1, 2017, 00:00

  • Hepatitis A and Hepatitis B Recombinant Vaccine Adherence In The United States

    Oct 1, 2017, 00:00

  • Quality of Life and Economic Burden Among Chronic Obstructive Pulmonary Disease (Copd) Patients in Japan

    Oct 1, 2017, 00:00

  • Psoriasis Drugs in Europe - Market Access Decisions in Comparision Based on the Prismaccess Database

    Oct 1, 2017, 00:00

  • Estimate European Candidates For Bronchoscopic Lung Volume Reduction (BLVR) Technologies In The Treatment Of Severe Emphysema

    Oct 1, 2017, 00:00

  • Análisis De La Relaciones De Mercado Entre El Seguro Obligatorio Y El Seguro Voluntario Para El Caso Colombiano

    Oct 1, 2017, 00:00

  • The Dynamics of Child Mental Health Care

    Oct 1, 2017, 00:00

  • A Systematic Review Of Economic Evaluations In Robot-Assisted Hysterectomy Use For Cervical Cancer Compared With Open And Laparoscopic Surgery

    Oct 1, 2017, 00:00

  • Clinical Comparison of First-Line Platin Chemotherapy Regimens In Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Using German Registry Data

    Oct 1, 2017, 00:00

  • Disclosure of Traditional and Complementary Medicine Used During Pregnancy and the Postpartum Period to Healthcare Providers

    Oct 1, 2017, 00:00

  • Lacosamide As First Line Treatment Option In Focal Epilepsy; A Cost-Utility Analysis for The Greek Healthcare System

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • Repellent And Larvicidal Activity Of Thai Medicinal Plants Against Mosquitoes- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • The Personalised Reimbursement Models (Prm)- Real World Data Collection to Provide Innovative Pricing Solutions in France

    Oct 1, 2017, 00:00

  • Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model For Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma- Dynamics of Quality of Life

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Surgical Approaches Total HIP Arthroplasty

    Oct 1, 2017, 00:00

  • Indicators of Participation in Cervical Cancer Screening Among Romany Women

    Oct 1, 2017, 00:00

  • Cost Utility Analysis of Infliixmab and Adalimumab Compared with Conventional Therapy in Patients with Crohn Disease in the Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Predicting Budget Impact- A Mixed-Effects Model Approach

    Oct 1, 2017, 00:00

  • Abaloparatide For Risk Reduction of Nonvertebral And Vertebral Fractures In Postmenopausal Women With Osteoporosis- A Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Web App Estimating Cost Savings And Clinical Outcomes Of Blood Glucose Monitoring Program. Example From The UK

    Oct 1, 2017, 00:00

  • Cost Analysis Of Drug-Related Probelms In Saudi Arabia, Patient And Health Care Professional's Perspective

    Oct 1, 2017, 00:00

  • Crosslinking to Corneal Keratoconus

    Oct 1, 2017, 00:00

  • Generic Competition and ITS Impact on Reference Pricing System and Medicnes Utilization in the Group of Sartans

    Oct 1, 2017, 00:00

  • Multiple Myeloma Patients’ Profile and Regimens Transitions in the Brazilian Private Health Sector

    Oct 1, 2017, 00:00

  • Understanding Stakeholder Expectations for Patient Engagement- A Qualitative Survey

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Ayahuasca Treatment For Substance Use Disorder (SUD) Patients In A Peruvian Centre

    Oct 1, 2017, 00:00

  • One Year Cost Of Ischemic Stroke And Intracranial Hemorrage According To Disability For Atrial Fibrillation Patients In France

    Oct 1, 2017, 00:00

  • Evaluation Of Wearable Technology Use In Clinician Outcomes Assessment Studies

    Oct 1, 2017, 00:00

  • German Amnog Benefit Assessment- The Type Of Appropriate Comparator Makes The Difference

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab (NIVO) Combined with Ipilimumab (IPI) Compared with Nivo and Ipi Monotherapies in The First-Line Treatment of Advanced Melanoma in The United States- Analysis Using 28-Month Overall Survival (OS) Data from Ch ...

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Patients with Metastatic Colorectal Cancer Using EQ-5D-5L

    Oct 1, 2017, 00:00

  • The Economic Impact of Dietary Sodium Reduction In Canada

    Oct 1, 2017, 00:00

  • Patients Acknowledge Adaptation- The Case Of Amputees

    Oct 1, 2017, 00:00

  • A Robust, Reproducible Method For Evaluating The Suitability of Disparate Observational Databases for Pooled Analysis, Using The Omop Common Data Model

    Oct 1, 2017, 00:00

  • Non-Proportional Hazards in Network Meta-Analysis- Efficient Strategies for Model Building and Analysis

    Oct 1, 2017, 00:00

  • Comparing The Estimated Health And Economic Benefits Of Herpes Zoster (HZ) Vaccines In The UK

    Oct 1, 2017, 00:00

  • A Conceptual Yet Pragmatic Framework for Value-Based Agreements

    Oct 1, 2017, 00:00

  • Skin Pain In Psoriasis

    Oct 1, 2017, 00:00

  • Trucs And CAR-TS - The Emergence Of Io Cell Therapies

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis And Its Role In Assessment Of Profitability In Poland

    Oct 1, 2017, 00:00

  • Resultados De La Implementación De Una Estrategia Combinada De Educación Y Gestión De Pacientes En Centros De Atención Primaria De Argentina

    Oct 1, 2017, 00:00

  • Economic Evaluation of the Change from An Opportunistic Cervical Screening Program to an Organized Screening in Catalonia, Spain

    Oct 1, 2017, 00:00

  • Direct Costs Of Inflammatory Bowel Diseases Therapy In Poland - Nationwide Database Analysis

    Oct 1, 2017, 00:00

  • Economic and Humanistic Burden of Illness Amongst Diabetes Patients Experiencing Treatment Inertia

    Oct 1, 2017, 00:00

  • A Comparison Of Markov Cohort And Discrete Event Simulation Models In Cost-Effectiveness Analysis Of Sorafenib And Everolimus In 3rd Line Metastatic Renal-Cell Carcinoma In The Czech Republic

    Oct 1, 2017, 00:00

  • Comparing The Healthcare Cost Utilization Of Paediatric Patients With Haemophilia A With And Without Inhibitors Treated At Instituto De Seguridad Social Del Estado De Mexico Y Municipios

    Oct 1, 2017, 00:00

  • Cost-Minimization of Adalimumab and Infliximab In Patients With Moderate To Severe Ulcerative Colitis Refractory To Conventional Therapy

    Oct 1, 2017, 00:00

  • Estimation of Prevalence In Rare Disease

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia

    Oct 1, 2017, 00:00

  • Differences In Labour Participation Between People Living With HIV And The General Population- Results From Spain Along The Business Cycle

    Oct 1, 2017, 00:00

  • Reducing Cognitive Burden In Discrete Choice Experiments

    Oct 1, 2017, 00:00

  • Risky Business- What Factors Influence Decision-Maker’s Willingness to Pay for New Treatments on the Hospital Formulary?

    Oct 1, 2017, 00:00

  • Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases- Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Racial Differences In The Prevalence of Cognitive Impairments And Dementia, Utilization of Chemo-Immunotherapy and Mortality In Elderly Diffuse Large B-Cell Lymphoma Patients

    Oct 1, 2017, 00:00

  • Single Versus Multiple Inhalers in Patients with Chronic Obstructive Pulmonary Disease (COPD)- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Novel Biologics Versus Conventional Preventive Therapies In Migraine- A Framework for Economic Evaluation

    Oct 1, 2017, 00:00

  • Assessing The Economic Impact Of The Introduction Of Daclatasvir In Combination With Asunaprevir For The Treatment Of Chronic Hepatitis C In China

    Oct 1, 2017, 00:00

  • A Model To Predict Costs And Outcomes Associated With Hyperkalaemia In Patients With Chronic Kidney Disease Or Heart Failure

    Oct 1, 2017, 00:00

  • Epidemiology of Psoriasis In Colombia- A Governmental Database Analysis

    Oct 1, 2017, 00:00

  • Are Accelerated Approval Mechanisms A Predictor To Early Access And Coverage? A Global Study Of Cancer Drugs

    Oct 1, 2017, 00:00

  • Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC)- A Mixed Treatment Comparison (MTC)

    Oct 1, 2017, 00:00

  • Modelling For Rare Diseases- Case of Canakinumab In Periodic Fever Syndromes In France

    Oct 1, 2017, 00:00

  • How Should We Value Orphan Drugs? Suggestions From A Large Public Opinion Survey

    Oct 1, 2017, 00:00

  • The Comparison of EQ-5D-5L Versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis

    Oct 1, 2017, 00:00

  • Evaluation of Anti-Asthmatic Potential of Artemisia Pallens Walls In Ovalbumin-Induced Airway Hyperresponsiveness in Laboratory Rats

    Oct 1, 2017, 00:00

  • Broadening The Valuation Space In Health Technology Assessment- The Case of Monitoring Individuals With Ocular Hypertension

    Oct 1, 2017, 00:00

  • Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • The Economic Impact Of Fibrin Sealants Used For Hemostasis In Coronary Artery Bypass Grafting Surgery; An Italian Perspective

    Oct 1, 2017, 00:00

  • Cost-Consequence Analysis of Using Neurofarmagen In The Decision-Making Process During The Treatment of Patients With Depression In The U.S

    Oct 1, 2017, 00:00

  • Role of Chemotherapy In The Current Treatment of Metastatic Melanoma

    Oct 1, 2017, 00:00

  • The Impact of Disease Duration and Disease Activity on the Cost of Rheumatoid Arthritis- Results from Burden of Rheumatoid Arthritis Across Europe a Socioeconomic Survey (BRASS)

    Oct 1, 2017, 00:00

  • Integrating Novel Screening Methods For Prostate Cancer, Cost-Utility Interventions

    Oct 1, 2017, 00:00

  • Creating Individualized HBA1C Targets Using Predictive Modeling

    Oct 1, 2017, 00:00

  • Implications of the German HTA-Process on Market-Uptake of Oral Treatments for Type-2-Diabetes (T2DM) Since 2007

    Oct 1, 2017, 00:00

  • Burden Of Cardiovascular Disease (CVD) For Patients With Familial Hypercholesterolemia (FH) Or Atherosclerotic Cardiovascular Disease (ASCVD) And The Impact Of Reducing Low Density Lipoprotein-Cholesterol (LDL-C) Lowering In Latin American ...

    Oct 1, 2017, 00:00

  • Amnog Dossiers As A Challenge for Pharmaceutical Companies- Is There A Correlation Between Volumes and Added Medical Benefit?

    Oct 1, 2017, 00:00

  • Comparison of Recent Hta Appraisals of Orphan Drugs By Nice, SMC And Has In 2015-2017

    Oct 1, 2017, 00:00

  • New Drugs Approval Timing In Italy (2015-2017)

    Oct 1, 2017, 00:00

  • Severity Of Kidney Disease In Systemic Lupus Erythematosus

    Oct 1, 2017, 00:00

  • Iron Deficiency Anemia In Patients With Chronic Inflammatory Bowel Disease (IBD)- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Real World Comparison of Persistence And Adherence Among Biologic Naïve Patients Initiating Apremilast or Biologics for The Treatment of Psoriasis In The United States

    Oct 1, 2017, 00:00

  • Prescription Costs Associated with A Pediatrician-Led Care Model Serving Children with Medical Complexities (CMC)

    Oct 1, 2017, 00:00

  • Secukinumab vs Adalimumab for The Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis At 48 Weeks from A Chilean Perspective

    Oct 1, 2017, 00:00

  • Using Mathematical Optimisation In Model-Based Cost-Effectiveness Analyses- A Case Study Of A Stratified Breast Screening Programme

    Oct 1, 2017, 00:00

  • Characteristics of Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • Estimating The Number of Relapsed And Refractory Indolent Lymphoma Patients Across Europe, Who Are Expected To Initiate A New Line of Therapy (LOT)

    Oct 1, 2017, 00:00

  • Merkel Cell Cancer- Poor Response To Chemotherapy Exposes Significant Unmet Need

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis For The Treatmet with Daclatasvir-Asunaprevir in Patients Naive with Chronic Hepatitis C Genotype 1b Without Baseline Ns5a Polymorphisms Under The Public Payer Perspective in Mexico

    Oct 1, 2017, 00:00

  • Costs of Managing Hypoglycaemias Among Insulin-Treated Patients with Diabetes- Results from the Hat Study in Brazil

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Potential Combined Vaccine Against Lyme Borreliosis And Tick-Borne Encephalitis In Slovenia

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Enstilar® for The Treatment of Psoriasis In Italy

    Oct 1, 2017, 00:00

  • Relative Efficacy and Tolerability of Lacosamide Versus Levetiracetam as Monotherapy for Adults with Newly Diagnosed Focal Seizures- A Post-Hoc Analysis of Randomized Clinical Trials

    Oct 1, 2017, 00:00

  • Budget Impact of Ribociclib Plus Letrozole For The Treatment of Post-Menopausal Women With Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2- Negative (HER2-) Advanced or Metastatic Breast Cancer From A US Private Th ...

    Oct 1, 2017, 00:00

  • Are Patient Outcomes Being Relegated By Nices Budget Impact Test?

    Oct 1, 2017, 00:00

  • EQ-5D-5L Population Norms For Moscow (Russia)- Interim Analysis

    Oct 1, 2017, 00:00

  • The Impact of Increase in The Proportion of Early Breast Cancer Cases on Costs and Outcomes

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Manufacturer Fees for Htas- Are They Promoting or Hindering Innovation?

    Oct 1, 2017, 00:00

  • Insight Into the Role of the General Practitioner in the Management of Colorectal Cancer- Record Linkage of the Netherlands Cancer Registry and the General Practitioner Database of the Pharmo Database Network

    Oct 1, 2017, 00:00

  • Systematic Literature Review On Multi-Indication Pricing Models In Oncological Drugs

    Oct 1, 2017, 00:00

  • Efectividad De Las Intervenciones En Cultura De Seguridad Del Paciente En Las Instituciones Hospitalarias- Revisión Sistemática

    Oct 1, 2017, 00:00

  • Cost-Effectiveness And Impact Of New Innovative Treatments On Prognosis Of Melanoma And Ovarian Cancer For Australian Patients

    Oct 1, 2017, 00:00

  • Multi-Disciplinary Decision Making In General Practice- A Case Study Of Switching Between Oral Anticoagulants

    Oct 1, 2017, 00:00

  • Assessing The Real-World Hospital Economic Burden Of Spinal Muscular Atrophy (SMA) In France

    Oct 1, 2017, 00:00

  • Clinical And Economic Outcomes Of Microinvasive Glaucoma Surgery (MIGS) With Stents In Patients With Mild-To-Moderate Or Refractory Glaucoma In Spain

    Oct 1, 2017, 00:00

  • But Will They Trade Health? Developing An Economic Value Framework for Oncology

    Oct 1, 2017, 00:00

  • Retrospective Analysis of Hospital Episode Statistics Data To Estimate The Economic Burden of Vaginal and Vulval Cancer in England (2009-2015)

    Oct 1, 2017, 00:00

  • Seleção Sistemática De Coortes Em Bases De Dados Assistenciais

    Oct 1, 2017, 00:00

  • Does the Real-World use of Pharmacological Therapy Follow Guidelines in Coronary Artery Disease Patients in Finland?

    Oct 1, 2017, 00:00

  • Improving Transparency In Health Technology Assessment

    Oct 1, 2017, 00:00

  • Real-World Multiple Myeloma Treatment Pattern In Lebanon- Evidence From Patient Chart Audit

    Oct 1, 2017, 00:00

  • Observed Versus Estimated Acquisition Costs Associated with Medicines Recommended by the All Wales Medicines Strategy Group

    Oct 1, 2017, 00:00

  • Can Missing Data Boundary Estimates Cast Doubt On Previous Conclusions Reevaluating A 10 Year Cost-Effectiveness Analysis (CEA) Of The Diabetes Prevention Program Outcomes Study (DPP/DPPOS)?

    Oct 1, 2017, 00:00

  • Psoriatic Arthritis Limits Patients’ Ability to Contribute to Society As Part of the Workfor Results from A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Resource Utilization and Treatment of Patient with Hepatocelullar Carcinoma – A Microcosting Analysis

    Oct 1, 2017, 00:00

  • An Analysis of Health-Related Quality of Life in People with Multiple Sclerosis in Ireland

    Oct 1, 2017, 00:00

  • A Health Technology Assessment of Hyperthermic Intraperitoneal Chemotherapy Added to Interval Cytoreductive Surgery in Stage III Ovarian Cancer

    Oct 1, 2017, 00:00

  • Health Insurance Cost of Affective Disorders In Hungary- A Cost of Illness Study

    Oct 1, 2017, 00:00

  • Feasibility And Acceptability Of Atrial Fibrillation Screening Using A Hand-Held ECG Device In General Practice Setting In Hong Kong

    Oct 1, 2017, 00:00

  • Preferences for Route of Administration, Frequency and Location – A Time-Trade-Off Study in the United Kingdom General Population

    Oct 1, 2017, 00:00

  • Human Papilloma Virus In Italy- Cost Of Illness And Potential Savings Due To HPV9 Primary Prevention

    Oct 1, 2017, 00:00

  • Dyslipidemia Treatment And CVD Risk In Adult Russians Who Reported Dyslipidemia

    Oct 1, 2017, 00:00

  • Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data

    Oct 1, 2017, 00:00

  • Does The Early Bird Catch The Worm- Early Cancer Detection And Survival In The UK

    Oct 1, 2017, 00:00

  • Effect Of Pharmaceutical Care Intervention On Well-Being Index Of Type 2 Diabetes Outpatients In A Tertiary Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Cost-Effectivenes Analysis of Anti-Tnf Use Compared To Dmards in The Fatal and Nonfatal Acute Coronary Ischemic Event

    Oct 1, 2017, 00:00

  • Investigation of Demographic Differences for Non-Small Cell Lung Cancer Patients with and Without Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Between-Hospital Variation of In-Hospital Mortality and 30-Day Readmissions in Acute Myocardial Infarction in Portugal- 2012-2014

    Oct 1, 2017, 00:00

  • Adesão A Terapia Antihipertensiva E Qualidade De Vida

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Haploidentical Vs Matched Unrelated Allogeneic Hematopoietic Stem Cells Transplantation in Patients Older Than 55 Years

    Oct 1, 2017, 00:00

  • The Economic Burden of Different Multiple Sclerosis Phenotypes

    Oct 1, 2017, 00:00

  • Impairment of Work Ability In Patients With Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Rare Diseases, Are Caregivers Just As Affected As Patients?

    Oct 1, 2017, 00:00

  • Market Dynamics of Statin Medications

    Oct 1, 2017, 00:00

  • Treatment Satisfaction and Burden of Illness With Oral Vs Injectable Multiple Myeloma Therapy in Patients with Newly Diagnosed Disease (NDMM)

    Oct 1, 2017, 00:00

  • Economic Burden Associated with Skeletal-Related Events in Patients with Bone Metastases in Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Molecular Versus Conventional Screening For Acute Intestinal Infectious Diseases- Novel Application Of Agent-Based Modelling

    Oct 1, 2017, 00:00

  • Assessment of Antidiabetic Drugs In Fran What Is The Basis For A Reimbursement Recommendation?

    Oct 1, 2017, 00:00

  • Calibrating Model-Consistent Transition Probabilities For Fibrosis Stages In NASH

    Oct 1, 2017, 00:00

  • A Cost Effectiveness Analysis of Obinutuzumab In The Management of Chronic Lymphocytic Leukemia In Greece

    Oct 1, 2017, 00:00

  • A Novel Atrial Fibrillation Evaluation Modelling Solution For NHS

    Oct 1, 2017, 00:00

  • Alemtuzumab Is The Most Cost-Effective Option In Comparison To Available Therapies In The Treatment of Rrms From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • An Effective Tablet Program For Collecting Pain Data From Patients

    Oct 1, 2017, 00:00

  • Economic Evaluation of Single Inhaler Triple Therapy For Patients With Chronic Obstructive Pulmonary Disease (COPD) Using The Galaxy Model

    Oct 1, 2017, 00:00

  • Tratamento Clínico De Obesidade Através De Internações Clínicas Em Spa- Impacto Econômico Da Judicialização

    Oct 1, 2017, 00:00

  • Is Willingness to Pay Higher for Cancer Prevention and Treatment?

    Oct 1, 2017, 00:00

  • Do Nice Appeals Make A Difference? Impact of Appeals on Appraisal Outcomes

    Oct 1, 2017, 00:00

  • The Impact of Scottish Medicines Consortium (SMC) Process Changes on Acceptance Rates for New Medicines for End of Life and Very Rare Conditions

    Oct 1, 2017, 00:00

  • A Systematic Review of Corticosteroids’ Role in the Management of Urolithiasis Patients

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Obinutuzumab Plus Chlorambucil in Patients with Previously Untreated Chronic Lymphocytic Leukemia and Coexisting Conditions

    Oct 1, 2017, 00:00

  • Investigating Comparator Requirements For Drug Selection For Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Determinants Of The Relationship Between Improved Glucose Control And Modeled Health Outcomes In Type 2 Diabetes Simulation Models

    Oct 1, 2017, 00:00

  • Assessing the Value of Decision Trees As A Method for Identifying Patient Subgroups

    Oct 1, 2017, 00:00

  • Health Technology Assessment Decisions in Immuno-Oncology Therapies- Results, Rationales, and Trends

    Oct 1, 2017, 00:00

  • Patient and Tumor Profiles in The Brazilian Private Setting- Data from The Auditron Claims Database

    Oct 1, 2017, 00:00

  • A UNIFORM PROBABILISTIC APPROACH TO MANAGE UNCERTAINTIES REGARDING VACCINE EFFECTIVENESS AGAINST SEROTYPE 3, 19A, NTHI AND HERD EFFECT IN THE BASE CASE OF A COST-EFFECTIVENESS ANALYSIS COMPARING NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D ...

    Oct 1, 2017, 00:00

  • Attitude Of Pharmacy Educators Towards Complementary And Alternative Medicines (CAM) Education In Pharmacy Curriculum- A Qualitative Exploration

    Oct 1, 2017, 00:00

  • Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • Safety And Effectiveness of Insulin Analogues Versus Human Insulin In Type 2 Diabetes; A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey

    Oct 1, 2017, 00:00

  • Burden Of Disease, Healthcare Pathways And Costs Of Primary Progressive Multiple Sclerosis- An Italian Real World Study On 10 Million Inhabitants

    Oct 1, 2017, 00:00

  • Subcutaneous Immunoprophylaxis As A Cost-Effective Treatment Alternative For Hepatitis B Virus-Related Transplant Patients In France

    Oct 1, 2017, 00:00

  • Burden of Lysosomal Acid Lipase Deficiency

    Oct 1, 2017, 00:00

  • Implementation of Nice Guidance for the Treatment of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Antimalarial Treatment Outcomes In Ethiopia- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Minimizing Bias In Indirect Comparisons Utilizing Virtual Patient Level Data

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns Of Patients With Ovarian Cancer Receiving First Line Chemotherapy In The United States

    Oct 1, 2017, 00:00

  • Barriers to the Introduction of Actual Technologies for Induction of Labor Management

    Oct 1, 2017, 00:00

  • Estimation Of The Cost Of Relapse In Schizophrenia- A Comparison Between Colombia, Panama And Mexico

    Oct 1, 2017, 00:00

  • Review of Rare Disease Registries Across EU5 Countries

    Oct 1, 2017, 00:00

  • Redets. 10 Years Of Full Economic Health Technologies Assessments (Medical Devices) In Spain (2006-2016)

    Oct 1, 2017, 00:00

  • A Comparison Of Systemic Pediatric Fluoroquinolone Use In South Korea

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis of An Increased Uptake of Alemtuzumab From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

    Oct 1, 2017, 00:00

  • The Utility of Different Approachs to Developing Health Utilities Data in Childhood Rare Diseases – A Case Study in Spinal Muscular Atrophy (SMA)

    Oct 1, 2017, 00:00

  • Systematic Review of Herpes Zoster Epidemiology- Available Evidence In Spain Related To Specific Sub-Populations

    Oct 1, 2017, 00:00

  • Are There Differences in Fact-G Scores Between Different Tumour Types for an EU Population Using Real World Data?

    Oct 1, 2017, 00:00

  • The Impact Of The Study Design Submitted For The Early Benefit Assessment On The Pricing For Oncologic Drugs

    Oct 1, 2017, 00:00

  • The Use of Published Real-World Evidence In HTA- An Analysis Of The Evidence Base Of Company Submissions In 2016 Nice Appraisals

    Oct 1, 2017, 00:00

  • Effect Of Hesperidin In Bleomycin-Induced Pulmonary Fibrosis In Rats- Critical Role Of NRF-2, TNF-Α, AND IL-1Β

    Oct 1, 2017, 00:00

  • Evaluating The Economic Burden And Health Care Utilization Of Bacterial Pneumonia In The US Department Of Defense Population

    Oct 1, 2017, 00:00

  • Surveillance Status, Diagnostic Accuracy And Survival Of The National Liver Cancer Surveillance Program

    Oct 1, 2017, 00:00

  • The Occurrence and Territorial Distribution of Acute Myocardial Infarctions in Hungary

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Stereotaxic Eeg (SEEG) As A Preoperative Diagnostic Procedure In Epilepsy Surgery

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Polypill for Patients with or at High Risk of Cardiovascular Disease in an NHS Setting

    Oct 1, 2017, 00:00

  • South West Icers – The Experience of Nice’s Diagnostics Assessment Programme

    Oct 1, 2017, 00:00

  • The Impact of Rheumatoid Arthritis (RA) on a Patient’s Ability to Stay in Work and Level of Pain Experienced

    Oct 1, 2017, 00:00

  • Estudos Econômicos De Belimumabe No Tratamento Do Lúpus Eritematoso Sistêmico - Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • The Attitude Of Parents To Non-Mandatory Vaccinations

    Oct 1, 2017, 00:00

  • Real World Evidence In Europe - The Results Of An Expert Survey

    Oct 1, 2017, 00:00

  • Age and Gender Relationships with Systemic Corticosteroid Induced Morbidity in Asthma- A Case-Control Study

    Oct 1, 2017, 00:00

  • Effect of Acrylic Monofocal Intraocular Lenses (IOLS) on ND-YAG Laser Capsulotomy Rates- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Qualitative Interviews To Inform Development Of A Patient Reported Outcome (PRO) Strategy In RLBP1 Retinitis Pigmentosa (RLBP1 RP)

    Oct 1, 2017, 00:00

  • Non Adherence to Inhalational Medications and Associated Factors Among Patients with Asthma in A Referral Hospital in Ethiopia, Using Validated Tool Tai

    Oct 1, 2017, 00:00

  • Comparative Efficacy and Safety of Regimens for Treating Plasmodium Falciparum Malaria- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Skin-Based Temperature Measuring With Different Thermometer Types

    Oct 1, 2017, 00:00

  • Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database

    Oct 1, 2017, 00:00

  • Efetividade Na Solicitação De Exames Laboratoriais Na Atenção Básica

    Oct 1, 2017, 00:00

  • EQ-5D-5L Utility Values For Spanish Patients With Painful Chronic Osteoarthritis, Low-Back-Pain Or Cancer Pain

    Oct 1, 2017, 00:00

  • Costs of Clinical Events in Diabetes Type 2 Patients in the Netherlands- A Systematic Review

    Oct 1, 2017, 00:00

  • Quality of Life (QOL), Functional Status (FS), and Survival in Triple Negative Breast Cancer (TNBC)- Discordance of Definitions Among a Targeted Literature Review and Stakeholder Interviews

    Oct 1, 2017, 00:00

  • Reliability Testing Of The Finnish Version Of The Non-Technical Skills Scale For Trauma (T-Notechs)

    Oct 1, 2017, 00:00

  • Barreras Y Facilitadores Para La Cobertura De Peritoneodiálisis En Chile

    Oct 1, 2017, 00:00

  • The Research And Suggestions On The Accessibility Of High Value Drugs In China

    Oct 1, 2017, 00:00

  • Study Of Polypharmacy At A Tertiary Care Teaching Hospital Bangalore

    Oct 1, 2017, 00:00

  • Lower Hemoglobin (HB) Levels Negatively Impact Quality Of Life (QOL) Among Peritoneal Dialysis (PD) Patients- Results From A National Representative Cohort Study In Brazil (BRAZPD)

    Oct 1, 2017, 00:00

  • How well does the leading pharmaceutical reform model work in china? --an interrupted time series analysis

    Oct 1, 2017, 00:00

  • Statistical Trend Analysis of German Benefit Ratings And Their Correlation With Negotiated Rebates Focusing on Orphan Oncologics

    Oct 1, 2017, 00:00

  • Costs And Effectiveness Of An Integrated Care Intervention For Muscle-Skeletal Diseases Transition From Primary Care To Specialized Hospital Care

    Oct 1, 2017, 00:00

  • Potential Therapeutic and Economic Value of Risk-Stratified Treatment as Initial Treatment of Multiple Myeloma in Europe

    Oct 1, 2017, 00:00

  • Evaluating Patient Reported Outcomes Commonly Used In Current Lung Cancer Clinical Trials

    Oct 1, 2017, 00:00

  • Primary Prevention of Hyperlipidemia- Treatment and Compliance in Real World Practice

    Oct 1, 2017, 00:00

  • Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) IN Patients With Type 2 Diabetes Mellitus In Serbia

    Oct 1, 2017, 00:00

  • The Economic Burden of Breast Cancer in Russia

    Oct 1, 2017, 00:00

  • Health Related Quality Of Life For Systemic Juvenile Idiopathic Arthritis (SJIA) Patients And Caregivers On Biologic Therapy, From A Caregiver’s Perspective

    Oct 1, 2017, 00:00

  • Risk-Stratified Breast Cancer Screening and Non-Adherence in Germany

    Oct 1, 2017, 00:00

  • Systematic Literature Review For Treatment Outcomes (Including Immuno-Oncology Treatment) Among Patients with Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC)

    Oct 1, 2017, 00:00

  • Costs of Grade 3 and 4 Adverse Events Associated with Current Cancer Treatments - Cost Estimations For Sweden, Norway, Finland And Denmark

    Oct 1, 2017, 00:00

  • Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain- Projections Based On The Dual VII Trial

    Oct 1, 2017, 00:00

  • Meta-Análise De Eficácia Da Atomoxetina Em Adultos com Transtorno De Déficit Da Atenção Com Hiperatividade

    Oct 1, 2017, 00:00

  • The Evaluation Of Assumptions In Cost-Effectiveness Model Development – A Case Of Dabigatran

    Oct 1, 2017, 00:00

  • Using A Mixed Methods Approach To Determine The Item-Scale Structure and Scoring for Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Elasticidad Precio De La Demanda Para Explorar Medidas Impositivas Que Desalienten EL Consumo De Bebidas Azucaradas Y Contribuyan a Prevenir Obesidad Y Diabetes Tipo II

    Oct 1, 2017, 00:00

  • Real-World Prevalence Of Mild To Moderate Hypoglycemic Events In Portugal - Results From The Hipos-Pharma Study

    Oct 1, 2017, 00:00

  • Adherence to Anti-Convulsant Therapy Among Ambulatory Epileptic Patients in a Tertiary Hospital in Nigeria

    Oct 1, 2017, 00:00

  • A Web-Based Hub Spoke Model For The Management Of HCV Patients And Innovative Treatments- The Resist - HCV Sicily Network Experience

    Oct 1, 2017, 00:00

  • Multiple Source of Information to Characterize the Clinical, Therapeutic Management and Economic Burden of Patients with Multiple Sclerosis in France

    Oct 1, 2017, 00:00

  • Managed Access Agreements (MAAS) In Appraisals Conducted By The National Institute For Health and Care Excellence (NICE)

    Oct 1, 2017, 00:00

  • Incidence of Respiratory Syncytial Virus Related Healthcare Utilization In The United States

    Oct 1, 2017, 00:00

  • Burden and Cost of Cancer Treatment in the Private Healthcare Setting in São Paulo State

    Oct 1, 2017, 00:00

  • Cost of Type 2 Diabetes Management And Associated Complications In Spain

    Oct 1, 2017, 00:00

  • National Survey Of Medication Safety Practice At Ministry Of Health Hospitals During Mass Gathering (Hajj-2016) In Saudi Arabia

    Oct 1, 2017, 00:00

  • Outcomes of Disease Activity In Rheumatoid Arthritis and Health Insuran Results From Real World

    Oct 1, 2017, 00:00

  • Agreement Between Patient And Clinician Ratings Of Disease Severity In Hidradenitis Suppurativa, Rheumatoid Arthritis, And Chronic Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Centralized Procurement of Medical Devices In Italy- A Methodology Towards Standardized Tender Dossier

    Oct 1, 2017, 00:00

  • Do People With Private Health Insurance Attach A Higher Value To Health Than Those Without Insurance? Results From An EQ-5D-5L Valuation Study In The Republic Of Ireland

    Oct 1, 2017, 00:00

  • Gender Differences In Heart Failure- The Arno Italian Experience

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Rhtnk-TPA Compared With RT-PA In The Treatment of Acute St-Segment Elevation Myocardial Infarction (Stemi) In China

    Oct 1, 2017, 00:00

  • Development of A New Patient-Reported Outcome Instrument To Evaluate Treatments For Stretchmarks- The Body-Q Stretchmark Scale

    Oct 1, 2017, 00:00

  • Transsexual’s Sex Reassigment Process In Brazilian National Health System- Where Are We?

    Oct 1, 2017, 00:00

  • Acceptance Of Indirect Comparisons In The German Early Benefit Assessment

    Oct 1, 2017, 00:00

  • Patient Reported Outcome Of Celiac Disease

    Oct 1, 2017, 00:00

  • The Influence Of Pharmaceutical Reform In Korea A Decade Ago- What We Walked

    Oct 1, 2017, 00:00

  • Analysis Of The Reimbursement Amount And The Actual Costs For Infusion Of Immunobiologics In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Quality of Life of Asthma Patients In Gree What Can We Do to Improve It?

    Oct 1, 2017, 00:00

  • Financial Group Incentives Improving Medication Persistence - Health Behavior Engineering Approach

    Oct 1, 2017, 00:00

  • Cost Study Of Immune Thrombocytopenia (ITP) Management From The French Hospital Perspective

    Oct 1, 2017, 00:00

  • FOLLOW-UP OF PEDIATRIC PATIENTS UNDER TREATMENT WITH SOMATROPIN IN BRAZIL THROUGH A PATIENT SUPPORT PROGRAM (PSP)

    Oct 1, 2017, 00:00

  • The Impact Of Patient Preference Studies In The German Healthcare System

    Oct 1, 2017, 00:00

  • Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

    Oct 1, 2017, 00:00

  • Beyond Product Value - A Holistic Approach For Value Assessment

    Oct 1, 2017, 00:00

  • Preoperative Smoking Cessation- Recording of Smoking Status in the Porvoo Hospital Area in Finland

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns In Metastatic And/Or Unresectable Gastric Cancer Patients In Russia

    Oct 1, 2017, 00:00

  • Economic Analysis And Evaluation Of The Value Of The Parallel Export Of Medicinal Products For Treatment Of Oncological Diseases In Bulgaria, 2016 T. VEKOV 1 AND G. KOLEV2

    Oct 1, 2017, 00:00

  • Understanding Patients’ Ability to Function in Order to Inform Clinical Benefit in Oncology Studies

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Tavi In Intermediate Risk Patients In France

    Oct 1, 2017, 00:00

  • Strategies To Effectively Prevent Surgical Site Infections In Italian Hospitals- Economic Benefits

    Oct 1, 2017, 00:00

  • Increasing Trend On Turkish Un-Licenced Medicine Market- A General Overview Analysis

    Oct 1, 2017, 00:00

  • Factors Influencing Innovative Drug Reimbursement In Poland

    Oct 1, 2017, 00:00

  • Análise Situacional Do Tratamento Cirúrgico Do Câncer Colorretal No Brasil

    Oct 1, 2017, 00:00

  • Cognitive Interviewing During Linguistic Validation Of Clinical Outcomes Assessments (COAS)- In-Person Or Video Chat – An Analysis Of Respondent Preference

    Oct 1, 2017, 00:00

  • Competency Analysis Of Community Pharmacists About Correct Use Of Metered Dose Inhaler

    Oct 1, 2017, 00:00

  • Denosumab And Bisphosphonates Persistence, Compliance And Switch In Patients With Solid Tumors (ST) And Bone Metastases (BM)

    Oct 1, 2017, 00:00

  • Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada

    Oct 1, 2017, 00:00

  • GLYCEMIC CONTROL IN PATIENTS WITH T2DM TREATED WITH SULFONYLUREAS ALONE OR IN COMBINATION WITH METFORMIN, ARGENTINA

    Oct 1, 2017, 00:00

  • New Insights In Metastatic Colorectal Cancer Treatment (MCRC) In 5 European Countries

    Oct 1, 2017, 00:00

  • Using Rasch Measurement To Quantify The Perceived Risks Associated With The Use Of Tobacco And Nicotine-Containing Products

    Oct 1, 2017, 00:00

  • Epidemiology and Clinical Characterisation of Obsessive- Compulsive Disorder in Bahawalpur Pakistan

    Oct 1, 2017, 00:00

  • Finding The Patient In Clinical Meaningfulness Through Rigorous Cognitive Interviews

    Oct 1, 2017, 00:00

  • Comparison of The Quality of Life In Elderly Population According To The Occurrence of Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • Análisis De Costo-Efectividad De La Monoterapia Con Rasagilina Comparada Con Pramipexol Para EL Manejo De Los Síntomas Motores En Pacientes Con Enfermedad De Parkinson Inicial En Colombia

    Oct 1, 2017, 00:00

  • Choice of Instrument Impacts Healthcare Decisions- Effect of Source of Utility Derived from the Same Patient Population on Cost-Effectiveness

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Nivolumab for The Treatment of People with Relapsed or Refractory Classical Hodgkin Lymphoma Following Autologous Stem Cell Transplant and Brentuximab Vedotin

    Oct 1, 2017, 00:00

  • Assessment of Hiv-Antiretroviral Adherence Using Refill Data From a National Administrative Database in Brazil

    Oct 1, 2017, 00:00

  • Retrospective Study On Italian Adpkd Disease Management Cost (REINA STUDY)

    Oct 1, 2017, 00:00

  • Evolution Cost-Effectiveness Analysis of Pharmaceutical Care for Type 2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns And Resource Use For Advanced Non-Small Cell Lung Cancer In Brazilian Private Institutions

    Oct 1, 2017, 00:00

  • Review of Surrogate Endpoint Validation Methodologies and Application In Solid Tumour Htas

    Oct 1, 2017, 00:00

  • Factors Contributing To The National Drug Expenditure Of Korea, 2010-2015- Focusing On The Core Therapeutic Classes

    Oct 1, 2017, 00:00

  • Identification of Real World Data Sources in Cancer in the Nordic Countries

    Oct 1, 2017, 00:00

  • Effect of Health System, Financing, and Macro-Economic Characteristics on The Migration of Foreign Physicians To Oecd Countries

    Oct 1, 2017, 00:00

  • Substantiation of the National Policy of Pricing and Availability of Drugs

    Oct 1, 2017, 00:00

  • Validation of Surrogate Endpoints In Melanoma Therapies and Use In HTA

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Results Of Highly Innovative Drugs Approved For Temporary Reimbursement In The Czech Republic

    Oct 1, 2017, 00:00

  • Evidence Map of Indirect Costs In Psoriasis and Psoriatic Arthritis Since 1960

    Oct 1, 2017, 00:00

  • The Burden of Spondyloarthritis – Paasport A Population-Based Study

    Oct 1, 2017, 00:00

  • The Prevalence and Treatment Status of Different Multiple Sclerosis Phenotypes in a Italian Reference Center

    Oct 1, 2017, 00:00

  • Disease Progression in Pediatric Multiple Sclerosis- A Narrative Review

    Oct 1, 2017, 00:00

  • Economic Evaluation of Exemestane Versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer from The Egyptian Health Care System Perspective

    Oct 1, 2017, 00:00

  • Minimally Important Differen Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology

    Oct 1, 2017, 00:00

  • Ameliorative Effect of Morin, A Bioflavonoid on Freund’s Adjuvant induced Established Polyarthritis in Rats

    Oct 1, 2017, 00:00

  • The Prevalence Of Chronic Health Conditions And Multimorbidity In The Portuguese Population - Results From The 2014 National Health Interview Survey

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of four Surgical Strategies for the Treatment of Functional Menorrhagia in France

    Oct 1, 2017, 00:00

  • Development Of A Tool To Quantify An Individual’s History Of Sun Exposure- Qualitative Phase Of The Development Of The Sun Exposure Questionnaire

    Oct 1, 2017, 00:00

  • Comparison Of Food And Drug Administration, European Medicine Agency And Swissmedic New Drug Approval- An Assessment Of The International Harmonization

    Oct 1, 2017, 00:00

  • Achieving Key Objectives In Rare Diseases Healthcare Policy In Spain- Contribution From A Dravet Syndrome Working Group

    Oct 1, 2017, 00:00

  • An Economic Evaluation Of Single Tablet Regimens Of Antiretroviral Therapy For Treatment-Naitve Hiv-Infected Patients

    Oct 1, 2017, 00:00

  • Value Of Treating All Liver Fibrosis Stages To Reach Elimination Of Diagnosed Chronic Hepatitis C- A Modelling Approach In France

    Oct 1, 2017, 00:00

  • Access and Secondary Use of Data Collected In An Electronic Medical Chart- Results Of The Real World Roswitch Study

    Oct 1, 2017, 00:00

  • The Budget Impact Of Introducing A PD-L1 Assay To Select Patients With Metastatic Nsclc Who Are Potential Candidates For Treatment With Immune Checkpoint Inhibitors

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared to Conventional Treatment From A Societal Perspective In Germany, France, Italy And The UK

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulant (DOAC) Adoption in Practi Utilization, Expenditures, Switching and Adherence

    Oct 1, 2017, 00:00

  • The Use of Mcda In HTA Decision Making In Bulgaria

    Oct 1, 2017, 00:00

  • Linguistic Validation Of Knowledge, Attitudes And Practice Of Zika Virus Disease Questionnaire Among The Malaysian General Public Using Rasch Model- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs- A Multi Criteria Decision Analysis For Rituximab And Bevacizumab

    Oct 1, 2017, 00:00

  • Vaccines for Herpes Zoster- A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age

    Oct 1, 2017, 00:00

  • Community Pharmacists' Interest In And Attitude To Pharmacy Practice Research In Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation- 3-Year Financial Projections For Three UK Regions

    Oct 1, 2017, 00:00

  • Burden of Disease on Chronic Heart Failure Patients- A Multinational Cross-Sectional Survey in Real World Setting

    Oct 1, 2017, 00:00

  • Trends in Pragmatic Clinical Trials

    Oct 1, 2017, 00:00

  • Drug Utilization in a Cardiology Unit of a Referral Hospital in Nigeria

    Oct 1, 2017, 00:00

  • Drugprice Developments After Patent Expiry

    Oct 1, 2017, 00:00

  • The Comparative Cost-Effectiveness of Cabozantinib, Everolimus and Axitinib in Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy- Scottish Perspective

    Oct 1, 2017, 00:00

  • Varying Nature Of The Assessment Of Advanced Medicinal Products (Atmp) In Germany

    Oct 1, 2017, 00:00

  • Un Marco Conceptual Para El Análisis De La Implementación De Los Componentes De La Salud Electrónica (E-Salud) Y Su Efecto En La Calidad En La Provisión De Servicios De Salud

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia- A Cost-Utility Analysis

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino EN EL Sector Público De Argentina

    Oct 1, 2017, 00:00

  • Quantifying The Relationship Between Hyperkalaemia And Outcomes In Patients With Heart Failure Or Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Treatments For Hepatitis C Virus- What’s New?

    Oct 1, 2017, 00:00

  • The Economic Impact of Optimizing Therapy In ‘Hard-To-Treat’ and ‘Harder-To-Treat’ Hypothyroid Patients by Changing the Levothyroxine Formulation from Tablets to Gel Caps

    Oct 1, 2017, 00:00

  • An Analysis of Translation Challenges When Adapting The Picture Naming Subtest of The Repeatable Battery for The Assessment of Neuropsychological Status (RBANS) for Use In Multinational Studies

    Oct 1, 2017, 00:00

  • Differences In Vaccine Pricing Between High-Income And Low-Income Markets

    Oct 1, 2017, 00:00

  • Economic Evaluation of Strategies for Opportunistic Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • Epidemiology of Locally Advanced or Metastatic Urothelial Cancer In The US, Europe And Japan

    Oct 1, 2017, 00:00

  • Investigating The Economic Impact Of HIV-Associated Renal And Bone Co-Morbidities In UK Inpatients Using The Hes Database

    Oct 1, 2017, 00:00

  • Patient-Preferred Design Features Of Tnf Inhibitor Self-Injection Devices- Insights From A Rheumatoid Arthritis Auto-Injector Preference Study

    Oct 1, 2017, 00:00

  • Outcomes And Costs Of Treating Hepatitis C With Direct-Acting Antivirals- Results From The German Hepatitis C-Registry

    Oct 1, 2017, 00:00

  • An Evaluation Of The Budget Impact Of The New 20% Subcutaneous Immunoglobulin (IG20GLY) For The Management Of Primary Immunodeficiency Diseases In Switzerland

    Oct 1, 2017, 00:00

  • Budget Impact Model of Secukinumab for Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis Treatment in Italy

    Oct 1, 2017, 00:00

  • Expenditure On Non-Pharmaceutical Products In Ireland During A Period Of Healthcare Cost Containment

    Oct 1, 2017, 00:00

  • Anticonvulsant Drugs Use Evaluation Survey Among Ambulatory Epileptic Patients In A Tertiary Teaching Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Comprehensive Knowledge and Uptake of Cervical Cancer Screening is Low Among Women Living with HIV/AIDS in Northwest Ethiopia

    Oct 1, 2017, 00:00

  • Infection Prevention In Heart Surgery In Germany- An Economic Analysis

    Oct 1, 2017, 00:00

  • Situation of Rheumatoid Arthritis Patients Treated with Biologics In Germany Based on a Claims Data Analysis

    Oct 1, 2017, 00:00

  • Value Communication Strategies for Immunotherapies in Nsclc- A Quick Evidence Assessment from The UK

    Oct 1, 2017, 00:00

  • Cost Minimization Analysis and Budget Impact Model of Treatment of Chronic Hepatitis C Virus with Grazoprevir (Gzr, Mk - 5172 / Elbasvir (Ebr, Mk - 8742) in Patients with Genotypes 1 and 4 in Mexico

    Oct 1, 2017, 00:00

  • 20th Euro - FDS Financial Disclosure Statements

    Oct 1, 2017, 00:00

  • Aplicação Da Mcda Nas Tomadas De Decisão Sobre Investimento Em Saúde – Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • Determining The Comparative Value Of Outcome-Based Money-Back Guarantee Scenarios In Non-Small Cell Lung Cancer Using Real-World Data

    Oct 1, 2017, 00:00

  • Quality Of Life In Patients With Knee Arthritis In Slovak Republic

    Oct 1, 2017, 00:00

  • The FDA Approval of Eteplirsen – Necessary Flexibility or a Worrying Precedent?

    Oct 1, 2017, 00:00

  • Impact of Collaborative Coustomized Patient Education in Psychiatric Diseases

    Oct 1, 2017, 00:00

  • A Comparative Study Between Hypertensive Patients with and without Co-Morbidities; Knowledge, Acceptance of Illness and Quality of Life as Quantifiable Variables in KPK, Pakistan

    Oct 1, 2017, 00:00

  • Utility Values Across Lines of Therapy in Immuno-Oncology Treatments- An Example from Advanced Melanoma

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Oral Glycopyrronium Bromide (Sialanar™) For The Symptomatic Treatment of Severe Sialorrhoea (DROOLING) In The UK Setting

    Oct 1, 2017, 00:00

  • Variation In Opioid Utilization By Physician Specialty And Payer Using A Linked Claims-Emr Database

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns In The Neurogenic Bladder Population- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Development And Evaluation Of Onconurse Practice− A Smartphone Application For Oncology Nurses

    Oct 1, 2017, 00:00

  • Fractional Polynomial Modelling In Network Meta-Analyses Of Cancer Immunotherapies In Advanced Non-Small Cell Lung Cancer (NSCLC)

    Oct 1, 2017, 00:00

  • Value Health With A Mobile APP- The Infant Health-Related Quality Of Life Instrument

    Oct 1, 2017, 00:00

  • Crohn’s Disease in Germany- A Claims Data Analysis of Therapies with Biological Agents

    Oct 1, 2017, 00:00

  • Haemorrhoidal Artery Ligation Procedure For The Treatment of Symptomatic Grade II–III Heamorrhoids- A Trial-Based And Long-Term Model-Based Economic Evaluation

    Oct 1, 2017, 00:00

  • The Use of The Eortc Item Library To Supplement Eortc Quality of Life Instruments

    Oct 1, 2017, 00:00

  • The Impact Of Co-Morbidity On The Disease Burden Of VTE

    Oct 1, 2017, 00:00

  • Análise De Significância Do Banco De Dados Da Saúde Suplementar – Ss No Brasil, Sob As Perspectivas Dos Atendimentos Em Hospitais E Demais Prestadores Particulares

    Oct 1, 2017, 00:00

  • Development of The Oiqol-A- A Health-Related Quality of Life Measure For Adults With Osteogenisis Imperfecta

    Oct 1, 2017, 00:00

  • Pharmacological Adherence to Clinical Guidelines in Acute Coronary Syndrome in Hospitals

    Oct 1, 2017, 00:00

  • Will It Blend? Incorporation Of IRP Within HTA Systems

    Oct 1, 2017, 00:00

  • Real World Effectiveness of Treatment With OBV/PTV/R ± DSV In HCV Patients With Cirrhosis In Poland

    Oct 1, 2017, 00:00

  • Estimating The Impact of Strategies For Cervical Cancer Prevention And Control In Indonesia Using Markov Model

    Oct 1, 2017, 00:00

  • Societal Preferences For Funding Orphan Drugs In The UK- A Person Trade Off Study

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Systematic Evaluation of Bevacizumab Treatment for Advanced Non-Small Cell Lung Cancer in China

    Oct 1, 2017, 00:00

  • Cost Containment And Privatisation Of Pharmaceutical Care In Gree A Review Of Policy Reforms Under The Memorandums’ Requirements

    Oct 1, 2017, 00:00

  • Analysis of Warfarin Usage and INR Control in Atrial Fibrillation- A Retrospective Study

    Oct 1, 2017, 00:00

  • Estudio De Costo Efectividad Del Factor De Coagulación Recombinante VIII Unido A Proteina Fc Para El Tratamiento De La Hemofilia A En Chile

    Oct 1, 2017, 00:00

  • Analysis of Factors Influencing the Level of Actual Benefit in Health Technology Assessment

    Oct 1, 2017, 00:00

  • Celebrity Deathmatch- Burden Of Disease VS RCTS In The Southern Cone Of Latin America

    Oct 1, 2017, 00:00

  • Assessment of Quality of Health Economic Studies In Non-Alcoholic Fatty Liver Disease

    Oct 1, 2017, 00:00

  • Budget Impact Analysis for Daclizumab Beta In Relapsing Remitting Multiple Sclerosis In Italy

    Oct 1, 2017, 00:00

  • Digital Real-World Evidence Platform- Taking the Burden Out of Melanoma Pain Reporting

    Oct 1, 2017, 00:00

  • Knowledge And Satisfaction Of Health Insurance Clients- Cross-Sectional Study Of A Tertiary Hospital Services In Ghana

    Oct 1, 2017, 00:00

  • The Influence Of Age On Patient Attitudes And Acceptability Towards Using Their Own Mobile Device To Record Patient-Reported Outcomes Data In Clinical Trials

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ferric Carboxymaltose (FCM) in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease (IBD)

    Oct 1, 2017, 00:00

  • Antibiotic Prescribing Pattern In Acute Upper Respiratory Tract Infections In Dubai

    Oct 1, 2017, 00:00

  • Varicella-Related Hospitalizations- Brazilian Retrospective Analysis After The Inclusion of A Vaccine in The National Immunization Program

    Oct 1, 2017, 00:00

  • How Will Payers Manage the Cost of New, Advanced Biologic and Oncologic Agents as Therapy Areas Become Crowded with Drugs with Similar Mechanisms of Action?

    Oct 1, 2017, 00:00

  • Systematic Literarture Review of Health-Related Quality of Life In Clostridium Difficile Infection

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Standard Therapy with Phosphocreatine VS Standard Therapy In Perioperative Management of Cardiac Surgery Patients With Extracorporeal Circulation, With Ischemic Heart Disease or With Chronic Heart Insufficienc ...

    Oct 1, 2017, 00:00

  • Inclusion of Comparator Single Arm Trials Used for Ema/Fda Registration In The Network Meta-Analysis Using Matching Adjusted Indirect Comparisons

    Oct 1, 2017, 00:00

  • Psychotropic Drug Use in Non Psychiatric Wards- Indian Scenario

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68 (current)
  • 69
  • 70
  • »